Allianz Asset Management Gmb H Gilead Sciences, Inc. Put Options Transaction History

Allianz Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $2.24 Million - $2.82 Million	33,600 Added 39.25%	119,200 $9.99 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $3.44 Million - $3.96 Million	54,400 Added 174.36%	85,600 $5.87 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $2.23 Million - $2.72 Million	31,200 New	31,200 $2.29 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.